home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Gaining Entry Into The Brain

  January, 9 2008 23:01
your information resource in human molecular genetics

Researchers have identified a protein used by aggressive immune cells seeking to breach the blood-brain barrier, reports a paper published online in Nature Immunology. Normally few immune cells enter the brains of healthy animals. However, neuroinflammatory disorders result in weakening of the blood-brain barrier, and entry of potentially dangerous immune cells into the central nervous system.

Alexandre Prat and colleagues show that the adhesion protein ALCAM acts as a 'foothold' for immune cells moving between blood-brain barrier endothelial cells. Blockade of ALCAM reduced the severity and slowed the progression of experimental autoimmune encephalomyelitis, a mouse model of human multiple sclerosis, and ALCAM worked synergistically with another adhesion molecule, ICAM1, to move immune cells across the blood-brain barrier.

Future work is needed to determine whether ALCAM blockade holds therapeutic utility in treating established human neuroinflammatory diseases.

Author contact:

Alexandre Prat (CHUM-Notre-Dame Hospital, Montreal, Canada)
E-mail: aprat@umontreal.ca

Abstract available online.

(C) Nature Immunology press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.